Tenon Medical Overview
Latest ROE for Tenon Medical: 783.99% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow783.99%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TNON is 783.99%. That is above the sector sector average of -5.72%. Investors often review this figure alongside Tenon Medical's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TNON currently prints 783.99% for ROE, while the sector average sits near -5.72%. That is roughly 13800.7% above the sector mean. Large gaps often invite a closer look at Tenon Medical's growth, margins, and balance sheet.
Return on Equity shows how effectively Tenon Medical converts resources into returns. At 783.99%, TNON may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TNON's ROE (783.99%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
